Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson’s Progression Markers Initiative (PPMI): a cross-sectional study.

The Parkinson’s Progression Markers Initiative (PPMI) is an ongoing observational, longitudinal cohort study of participants with Parkinson’s disease, healthy controls, and carriers of the most common Parkinson’s disease-related genetic mutations, […]

» Read more
1 2 3 4